🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Sjogren Syndrome

Rare AutoImmune SElf-management Programme Development NCT06642870n/a1 site📍 Bristol University of the West of England · Tests: Non-interventional study Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases NCT06828042Phase 1, Phase 21 site📍 Beijing Peking University Third Hospital · Tests: anti-CD19 CAR T cell therapy BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases NCT07184450Phase 11 site📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: BCMA/CD70-targetd CAR-T A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases NCT07167537Phase 11 site📍 Beijing Beijing GoBroad Hospital · Tests: OL-CD19-GDT TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE NCT07153276Phase 41 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Fractional CO2 laser (vaginal), Promestriene Vaginal Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients NCT07249060n/a1 site📍 Pamplona Hospital Universitario Araba · Tests: Immune Checkpoint Inhibitors Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye NCT05605314n/a1 site📍 Beijing Peking University Third Hospital · Tests: Cyclosporine AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. NCT06991114Phase 252 sites📍 Tuscaloosa📍 Phoenix📍 Tucson Artiva Biotherapeutics, Inc. · Tests: Allogeneic NK Cells Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH NCT06947460Phase 1, Phase 21 site📍 Beijing Beijing GoBroad Hospital · Tests: CD19-BCMA CAR-T cells infusion Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies NCT06875102NA1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Acupuncture (ACU), Transcutaneous Vagus Nerve Stimulation (tVNS), APA (adapted physical activity ), Acupuncture (sham_A… Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases NCT06732674NA1 site📍 Oslo Oslo University Hospital · Tests: A home monitoring strategy with event driven management Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. NCT06947473Phase 1, Phase 21 site📍 Beijing Beijing GoBroad Hospital · Tests: umbilical cord blood CD19-BCMA CAR-T cells infusion A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease NCT07041099Phase 114 sites📍 Orlando📍 Brooklyn📍 Memphis Cullinan Therapeutics Inc. · Tests: CLN-978 Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome NCT07277257Phase 41 site📍 Venice Center For Sight · Tests: TRYPTYR (Acoltremon ophthalmic solution 0.003%) Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO NCT03816345Phase 152 sites📍 Birmingham📍 Palo Alto📍 Sacramento National Cancer Institute (NCI) · Tests: Biospecimen Collection, Cabozantinib, Fluoropyrimidine, Ipilimumab, Nivolumab Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy NCT03509064n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Collection sheet Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site📍 Beijing Peking University Third Hospital · Tests: BCT301 A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases NCT07123519Phase 11 site📍 Tianjin China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease NCT07281456Phase 21 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… · Tests: Tofacitinib Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases NCT06614270NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Anti-CD19 IL-10/IL15 CAR-NK The Myelin Disorders Biorepository Project NCT03047369n/a23 sites📍 Los Angeles📍 Orange📍 Palo Alto Children's Hospital of Philadelphia
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy